NTAGI will review data on COVID vaccines for children ages 5-12
- The COVID-19 Task Force of the National Technical Advisory Group on Immunization will review the data on COVID vaccines for children ages 5-12 on May 4.
- The second-level Permanent Technical Subcommittee will reportedly review and discuss the working group’s recommendations after checking the safety and efficacy data on COVID vaccines.
- DCGI granted an emergency use authorization to Biologics E’s Corbevax for children 5 to 12 years of age and Bharat Biotech’s COVAXIN for children 6 to 12 years of age.
- Prime Minister Modi stressed that the government’s priority is to vaccinate all eligible children as soon as possible with unique campaigns in schools.
Delhi High Court Notice to Government on Petition to Enact Law on Compulsory Registration of Muslim Marriages
- The Delhi High Court has sought a response from the Central Government to a petition from a Muslim woman seeking direction to enact a law for compulsory registration of Muslim marriages.
- She and her 11-month-old son have been abandoned by her Muslim husband. The petitioner has also sought instructions to declare and be legally bound to obtain the prior written consent of her wives for the polygamy contract under Sharia law.
- The petition states that the petitioner has filed this petition as a Public Interest Litigation since the relief requested is of public importance.
- The allegation further asserts that the Holy Quran establishes polygamy only in extreme and extraordinary passages.
Home Minister Amit Shah to inaugurate Nripathunga University, NATGRID campus in Bangalore
- Union Home Minister Amit Shah is scheduled to inaugurate Nripathunga University and the NATGRID campus in Bangalore on May 3.
- He is likely to start the day by paying homage to Sri Basavanna at Basav Jayanti at 10 am at Basaveshwara Circle.
- The Union Minister will lay the foundation stone for Nripathunga University, formerly the Government Science College.
- It was founded by the then Mysore Maharaja Nalwadi Krishnaraja Wadiyar. He started teaching postgraduate courses in a research program at an undergraduate university and later obtained university status in 2020.
Molecule discovered by IIT Mandi to treat diabetes
- Researchers at the Indian Institute of Technology (Mandi) have identified a drug molecule that can be used to treat diabetes.
- A molecule called ‘PK2’ can trigger the release of insulin from the pancreas and could potentially be used as an orally administered drug for diabetes.
- The research findings have been published in the Journal of Biological Chemistry and authored by Dr. Prosenjit Mondal, Associate Professor in the Faculty of Basic Sciences.